Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Bifidobacterium lactis MAK16B42L and Increased PMN Cell Phagocytic Capacity

Research synthesisModerate evidenceModerate effect4 studies · 3 beneficial · 1 neutral · 0 harmful

Across 4 studies, 3 reported beneficial effects of Bifidobacterium lactis on PMN cell phagocytic capacity, with effect sizes ranging from moderate to large. A meta-analysis found a large effect (SMD 0.74, p < 0.001). Most evidence comes from healthy elderly adults, but doses and durations were not consistently reported across studies.

  • Studied populations: elderly adults

Caveats: Evidence base is small (only 4 studies) — conclusions should be considered preliminary. The studies used different B. lactis strains (HN019, DGCC 420) rather than the specific MAK16B42L strain, so applicability is uncertain. One study showed a neutral effect, suggesting variability in outcomes.

Generated Jul 11, 2026
4 of 4 papers
Back to top